login
login
Image header Agence Europe
Europe Daily Bulletin No. 12978
Contents Publication in full By article 43 / 44
NEWS BRIEFS / Health

European Medicines Agency recommends Novavax’s Covid-19 vaccine for adolescents aged 12-17 years

23/06/2022 (Agence Europe)The European Medicines Agency (EMA) recommended, on Thursday 23 June, an extension of the use of the vaccine developed by the firm Novavax CZ, a.s, called Nuvaxovid, in adolescents aged 12 to 17 years. The adjuvanted recombinant nanoparticle subunit vaccine was already licenced in the European Union for use in adults aged 18 years and over. (EV)

Contents

EUROPEAN COUNCIL
EUROPEAN PARLIAMENT PLENARY
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
COURT OF JUSTICE OF THE EU
Russian invasion of Ukraine
NEWS BRIEFS